Neurocrine Bioscienc (NQ: NBIX )
152.36
-0.21
(-0.14%)
Streaming Delayed Price
Updated: 1:50 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Neurocrine Bioscienc
![](https://www.investors.com/wp-content/uploads/2021/08/Stock-BullPaintedRushing-adobe.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/09/2.0-voyager-pipeline_desktop-patient-resources_circle.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/25/aapharma.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/30/aapharma_7.png?width=1200&height=800&fit=crop)
Neurocrine Biosciences Buys UK-Based Hormone Therapy Player
August 30, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/05/aapharma_13.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2022/08/Stock-neurocrinebio-01-shutt.jpg)
![](https://www.investors.com/wp-content/uploads/2018/01/Stock-climberSilo-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/07/nbix_logo_light__12134bbdd373277108445dcfedb2f189.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/23/screenshot_2022-11-23_at_7.14.20_pm.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2022/11/Stock-neurologybrain-02-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/14/image18.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_22686.jpeg?width=1200&height=800&fit=crop)
![](https://www.marketbeat.com/logos/articles/small_stock-image_20038039_S.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_3479.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2022/06/Stock-jeromepowell2022-02-gov.jpg)
![](https://www.investors.com/wp-content/uploads/2022/08/Stock-neurocrinebio-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_1765.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_27899.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9169.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/704064/scientists-in-a-lab.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_27199.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_4331.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2022
September 26, 2022
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2020/04/Stock-MedicalStock-02-shutt.jpg)
![](https://www.investors.com/wp-content/uploads/2022/05/Stock-devonenergyoilrig-01-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2017/12/Stock-biotech-12-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2020/01/A1MAIN-biotech-011020-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2017/08/HTI-WALLSTREET-adobe.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.